GlassScriptPhysician profile
Vanessa Pickard
NPI 1235431008
$7,531.91
in general payments reported to CMS, 2019-2025
52 companies · $471 in 2025
The $471 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,591 · 2022: $2,008 · 2023: $1,634 · 2024: $828 · 2025: $471.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,933.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,932.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,289.48 | 2021-2024 | |
| Novo Nordisk INC | $770.82 | 2021-2024 | Wegovy, Ozempic, Rybelsus |
| Corium, LLC | $562.89 | 2022-2025 | Azstarys |
| Biohaven Pharmaceutical Holding Company LTD. | $337.22 | 2022 | |
| Pfizer INC. | $315.55 | 2021-2024 | |
| Merck Sharp & Dohme LLC | $280.49 | 2021-2024 | Verquvo, Belsomra |
| Glaxosmithkline, LLC. | $247.77 | 2021-2024 | Shingrix, Arexvy, Trelegy Ellipta |
| Amgen INC. | $246.60 | 2021-2024 | Repatha, Otezla |
| Arbor Pharmaceuticals, INC. | $246.46 | 2021-2022 | |
| Corcept Therapeutics | $223.66 | 2024-2025 | Korlym |
| Clarus Therapeutics INC. | $215.91 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $214.88 | 2021 | |
| Amarin Pharma, INC. | $211.69 | 2021-2022 | |
| Exact Sciences Corporation | $196.89 | 2023-2025 | Cologuard Collection Kit |
| Lilly USA, LLC | $193.34 | 2021-2024 | Mounjaro, Zepbound, Jardiance |
Show all 52 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vanessa Pickard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.